Les Weinstein was appointed as the first CDRH Ombudsman in 2000. As an external Ombudsman, 

he looks into complaints from outside the agency and facilitates the resolution of disputes between 

CDRH and the medical device industry it regulates. While providing this service, he maintains his 

impartiality and neutrality. This Annual Report focuses on complaints, disputes, and inquiries: the 

number of contacts the Ombudsman received, their source, the CDRH offices involved, the 

subjects, reasons and disposition.

A complaint is typically an expression of dissatisfaction, perhaps about timeliness, lack of 

communication, or an unhelpful employee. A dispute usually involves a disagreement with, a 

challenge to, or an appeal of a decision or action the Center has taken or is about to take. An 

inquiry may be a question or an issue that does not rise to the level of a complaint or a dispute.

Complaints: 54%

Disputes: 18%

Inquiries: 28%

Industry: 81%

Consumers: 8%

Health Care Providers: 5%

Misc: 6%

Office of Center Director (OCD): 1%

Office of Communication, Education, and Radiation Programs (OCER): 4%

Office of Compliance (OC): 26%

Office of Device Evaluation (ODE): 65%

Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD): 9%

Office of Management Operations (OMO): 1%

Office of Science and Engineering Laboratories (OSEL): 0 %

Office of Surveillance and Biometrics (OSB): 1%

510(k): 19%

PMA/IDE/HDE: 8%

Imports: 5%

Registration & Listing: 5%

CDRH Ombudsman Annual Report - Calendar Year 2008

U.S. Department of Health and Human Services

Public Health Service

Food and Drug Administration

Center for Devices and Radiological Health

I. CONTACTS

A. Number received: 170

B. Source of Contacts:

C. CDRH Office mentioned in Complaints, Disputes, and Inquiries; or Office referred to by the 

Ombudsman for assistance in resolution or response:

(Some may include more than one Office.)

D. Subject of Complaints, Disputes, and Inquiries: (Only those 2% or more of the total are listed.)

About FDA

Home About FDA FDA Organization Office of Medical Products and Tobacco

CDRH Reports > CDRH Ombudsman Annual Report - Calendar Year 2008 Page 1 of 3

mhtml:https://permanent.fdlp.gov/lps80039/Calendar%20year%202008/CDRH%20Repo... 2020-03-03
Page Last Updated: 11/07/2011 

Note: If you need help accessing information in different file formats, see Instructions for 

Downloading Viewers and Players. 

Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency

Website Policies

U.S. Food and Drug Administration

10903 New Hampshire Avenue 

Silver Spring, MD 20993 

Ph. 1-888-INFO-FDA (1-888-463-6332)

Email FDA

For Government For Press

Combination Products Advisory Committees Science & Research Regulatory Information Safety

Emergency Preparedness International Programs News & Events Training and Continuing

Education Inspections/Compliance State & Local Officials Consumers Industry Health

Professionals

513g: 3%

Adverse Event/MDR/Safety: 3%

Inspection: 3%

Classification/Reclassification: 3%

Clinical Trial: 3%

Company Whistleblower: 3%

De Novo: 2%

Laser: 2%

Combination Product: 2%

FOIA/Disclosure: 2%

Pre-IDE: 2%

CDRH Meetings with Company: 2%

FDA Website: 2%

Recall: 2%

1. Miscommunication or lack of communication 

2. Data/testing requirements to support a submission; not “least burdensome” 

3. Lack of timeliness (of approval/clearance; scheduling meetings; returning phone calls, etc.) 

4. Various policies and procedures 

5. Level playing field (claim of unequal treatment) 

Closed (Complaint addressed, dispute resolved, or inquiry responded to): 81%

Pending at end of 2008: 19%

In 2008, the Ombudsman did not receive any requests for review of a scientific dispute by the 

Medical Devices Dispute Resolution Panel.

E. Most Common Reasons for Complaints, Disputes, and Inquiries by rank:

F. Year-end Status of Complaints, Disputes, and Inquiries, excluding those that were referred outside 

CDRH, withdrawn, or had no follow-up by the initiator: (Includes cases received in 2008 plus those 

pending from previous years that had been carried over to 2008.)

II. MEDICAL DEVICES DISPUTE RESOLUTION PANEL

CDRH Reports > CDRH Ombudsman Annual Report - Calendar Year 2008 Page 2 of 3

mhtml:https://permanent.fdlp.gov/lps80039/Calendar%20year%202008/CDRH%20Repo... 2020-03-03
Links on this page:

CDRH Reports > CDRH Ombudsman Annual Report - Calendar Year 2008 Page 3 of 3

mhtml:https://permanent.fdlp.gov/lps80039/Calendar%20year%202008/CDRH%20Repo... 2020-03-03